AI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup leverages AI-driven automation to address the inefficiencies and errors in traditional drug safety monitoring. This funding will accelerate product innovation and global market expansion for their SaaS platform.